🇺🇸 US Stock Screener ← Switch market ⚡ HerAI

Bio Green Med Solution, Inc. BGMS

Industrials · Building Products & Equipment · Malaysia
https://bgmsglobal.com
Company Profile ↓
$0.87
-90.19% 1Y
Mkt Cap$5.76M
P/E-0.18
P/B0.79
52W High$8.90
52W Low$0.60
Book Value$1.08
EPS (TTM)$-4.95

Company Overview

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green Med Solution, Inc. was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 34.4%, reflecting efficient use of shareholder capital.

Recent Developments

  • Trailing 12 Months Year-on-year growth — revenue -100.0%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-
1 Year:-100.00%

Stock Price Performance

1 Year:-90.19%
6 Months:-7.13%
3 Months:-20.64%
1 Month:-8.11%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 3% of range
$0.60 $8.90
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)47.16 · Neutral
Price Performance
1M-8.11%
3M-20.64%
6M-7.13%
1Y-90.19%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Strong return on equity of 34.4%.

CONS

  • Trading 90.2% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.18
Industry PE
26.00
Forward P/E
-
PEG Ratio
-
Book Value
$1.08
Price to Book
0.79
P/S
3.04
EV/EBITDA
-0.55
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-
Profit 5Y
-
Revenue (YoY)
-100.00%
Earnings (YoY)
-

Profitability & Returns

ROCE
-122.97%
ROE
34.40%
ROA
-37.00%
Profit Margin
-
Op Margin
-
Gross Margin
-24.23%
EPS (Latest Qtr)
$-1.31
EPS (TTM)
$-4.95

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
7.03
Current Ratio
8.63
Debt
$0
Total Assets
$7.56M
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
33.92%
Chg in Prom Hold
-11.28%
FII / Inst Holding
1.54%
Chg in FII Hold
-0.25%

Financial Snapshot

Enterprise Value
$5.76M
Total Revenue (TTM)
$1.86M
EBITDA
$-3.62M
Free Cash Flow
$-3.66M
Operating Cash Flow
$-1.10M
Shares Outstanding
6.62M
Gross Margin
-24.23%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Industrials).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 BGMS Bio Green Med Solution, Inc. 0.87 -0.18 $5.76M 0.00% -122.97% 34.40% - -
2 SPCX Space Exploration Technologies Corp. R3KAIDEFENCE 153.47 -139.52 $1.16T 0.00% -3.22% -11.95% 34.08% -3.34%
3 CAT Caterpillar Inc. SPXR3K 822.48 35.47 $378.07B 0.79% 17.98% 56.97% 2.29% 5.24%
4 GE GE Aerospace SPXR3KDEFENCE 334.91 39.40 $347.49B 0.60% 9.52% 48.23% -7.42% -5.36%
5 RTX RTX Corporation SPXR3KDEFENCE 198.81 35.06 $267.95B 1.51% 8.28% 12.27% 2.61% 2.62%
6 GEV GE Vernova Inc. SPXR3KAI 971.31 27.86 $258.69B 0.22% 6.30% 82.58% 8.68% -
7 DE Deere & Company SPXR3K 680.73 37.88 $183.54B 0.95% 12.53% 18.24% 3.43% 5.10%
8 UNP Union Pacific Corporation SPXR3K 288.45 23.38 $171.36B 2.01% 15.22% 39.70% 2.30% 7.77%
9 BA The Boeing Company SPXR3KDEFENCE 210.73 75.80 $166.43B 0.00% -9.01% - 1.67% -3.28%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2013Jun 2013Sep 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue ---------------------------------------743.00K
Operating Income -4.05M-4.15M-5.79M-5.41M-5.58M-5.67M-5.30M-3.62M-3.39M-3.74M-3.76M-3.48M-2.69M-2.49M-2.11M-2.16M-2.46M-2.46M-2.20M-2.34M-2.35M-2.42M-2.47M-2.57M-4.30M-6.10M-6.00M-6.56M-5.79M-6.47M-7.32M-5.93M-6.84M-4.36M-3.64M-2.18M-4.21M-1.32M-992.00K-246.00K
Net Income -3.08M1.49M-5.00M-4.87M-4.81M-4.91M-4.91M-3.35M-2.71M-3.04M-2.96M-2.95M-1.55M-2.19M-1.86M-1.35M-1.85M-2.07M-1.84M-1.78M-1.90M-1.22M-2.17M-2.26M-3.48M-5.13M-4.99M-4.11M-4.58M-5.10M-5.80M-5.45M-6.03M-2.95M-3.26M-1.96M-81.00K-1.32M-988.00K-197.00K
Diluted EPS -0.10---0.22--------------------0.50-0.56-0.54-0.42-0.46-0.42-7.00-0.44--2.27-172.18-43.800.00-0.98-1.31-
R&D Expense 1.58M2.63M4.58M4.34M4.54M4.97M4.34M2.58M2.90M2.50M2.64M2.41M1.31M1.22M958.00K798.00K1.18M1.21M1.01M1.15M1.06M1.11M1.16M1.07M2.57M4.10M4.22M4.95M4.21M4.41M5.67M4.73M5.24M2.80M2.02M950.00K822.00K68.00K5.00K-

Profit & Loss (Annual)

Figures in USD.

Metric Mar 1998Mar 1999Mar 2000Mar 2001Mar 2002Mar 2003Dec 2004Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -----------911.00K112.00K699.00K69.00K1.08M1.73M1.94M843.00K0150.00K-000420.00K43.00K0
Operating Income ------------18.30M-15.13M-15.75M-15.10M-17.97M-22.44M-16.17M-14.15M-9.49M-9.55M-9.68M-10.64M-22.94M-27.66M-25.45M-12.00M-8.43M
Net Income -2.53M-3.96M-5.69M-10.38M-14.85M-15.54M-22.74M-18.05M-29.26M-24.05M-40.39M-19.57M-16.02M-15.24M-13.19M-10.15M-19.39M-14.34M-11.79M-7.47M-7.29M-7.83M-8.45M-18.89M-21.20M-22.55M-11.21M-3.00M
Diluted EPS -----------------------3.42-2.14-27.24-26.75-502.46-6.45
R&D Expense -----------9.77M6.41M9.21M6.59M11.28M18.28M12.38M9.48M4.24M4.33M4.66M4.76M15.48M20.27M19.16M6.66M848.00K

Balance Sheet (Annual)

Figures in USD.

Metric Mar 1997Mar 1998Mar 1999Mar 2000Mar 2001Mar 2002Mar 2003Dec 2003Dec 2004Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --------------31.46M26.00M19.35M35.52M29.39M24.76M19.66M26.00M19.82M15.31M36.80M42.59M28.05M8.80M4.09M8.19M
Total Equity -293.00K2.01M-1.54M7.98M-2.59M-15.08M-32.15M37.65M23.95M4.12M53.92M57.97M20.64M5.87M24.92M19.50M10.02M28.02M21.69M18.84M14.27M21.77M15.27M11.70M33.26M37.69M15.94M607.00K-2.17M6.84M
Cash & Equivalents ------------24.22M11.49M29.50M24.45M16.41M31.15M24.19M20.44M16.52M23.91M17.50M11.88M33.41M36.56M18.34M3.38M3.14M3.50M
Total Liabilities --------------6.54M6.50M9.34M7.50M7.70M5.93M5.39M4.24M4.55M3.61M3.54M5.32M7.62M8.20M6.27M1.34M
Current Liabilities --------------6.54M6.50M9.34M7.26M7.49M5.75M5.26M4.11M4.45M2.42M2.49M5.29M7.51M8.16M6.27M1.33M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow ---------7.48M-6.70M-9.45M-7.93M-18.54M-20.83M-16.11M-7.99M-4.77M
Investing Cash Flow ---------13.00K-39.00K28.00K-96.00K-27.00K-7.00K-6.00K--
Financing Cash Flow --------14.75M429.00K3.85M29.50M21.74M3.00M848.00K7.82M5.26M
Capital Expenditure -15.00K-8.00K-6.00K-12.00K-208.00K-309.00K-34.00K-3.00K-13.00K-39.00K-10.00K-96.00K-27.00K-7.00K-6.00K--
Free Cash Flow ---------7.49M-6.74M-9.46M-8.03M-18.57M-20.83M-16.12M--

Ratios (Annual)

Figures in %.

Metric Mar 1998Mar 1999Mar 2000Mar 2001Mar 2002Mar 2003Dec 2004Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ----------------------------
Operating Margin % ------------2,009.2%-13,513.4%-2,252.9%-21,888.4%-1,658.1%-1,293.9%-831.8%-1,678.5%--6,365.3%-----6,060.2%-27,916.3%-
Net Margin % ------------2,148.2%-14,304.5%-2,180.7%-19,110.1%-936.6%-1,118.1%-737.8%-1,398.7%--4,858.7%-----5,370.2%-26,074.4%-
ROE % -126.1%257.7%-71.2%400.8%98.5%48.3%-94.9%-438.2%-54.3%-41.5%-195.6%-333.3%-64.3%-78.2%-131.6%-36.2%-89.4%-76.1%-82.6%-34.3%-47.7%-66.9%-25.4%-50.1%-133.0%-3,715.8%515.7%-43.8%
ROCE % -------------60.7%-80.8%-150.7%-63.6%-102.5%-85.1%-98.2%-43.4%-62.1%-75.1%-31.0%-61.5%-134.7%-3,952.3%552.2%-123.0%

Shareholding Pattern

Insiders
33.92%
Institutions
1.54%
Public Float
2.34%

Top Institutional Holders

#Holder% HeldSharesValue
1 Citadel Advisors Llc 1.36% 75.24K $70.50K
2 Jane Street Group, LLC 0.30% 16.29K $15.26K
3 Tower Research Capital LLC (TRC) 0.10% 5.72K $5.36K
4 UBS Group AG 0.08% 4.33K $4.06K
5 SBI Securities Co., Ltd. 0.01% 701 $656
6 Archer Investment Corp - 1 $0
7 Osaic Holdings Inc. - 1 $0

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for BGMS

Google News Fri, 05 Jun 2026

Bio Green Med Solution (BGMS) surges after announcing all-stock business combination with Future NRG - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxQT1N0SFpzRGszUHhpMnlwYVB4aEF4RkExdmhtZ2ppbEFVYkxMcnNQalVwX3lhRzFCQVY4dWxacjlfaVBfamJJcUIwcmFKQ0JhSFl6dWlDQXM2UHlzYl9ndF9wNEw2MFpXQXpnR1JTcFpTSnJzaFhHdGFZdkE1N1YyZjdkQU9PbWE2OTI3MU…

Google News hu, 04 Jun 2026

Bio Green Med plans merger with Malaysia medical-waste innovator Future NRG - Stock Titan

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxNY3RvQlg0SjlWZXZnZ2tHcTNvdHMwSGJ0RkhjNmNUY1V6VEtRUktabk9Ia2hBWXN2dFFkTm9INHRSbk1FcTh4Nk5zN21yXzBlc0VVcjk2a2hKWHlRLWhPS0xjSEJNQS16cUxTdld5Ty1pd3lOZkNRbFdKNk1LdHV4cW5HWDJxazhWai1iaU…

Google News hu, 04 Jun 2026

Bio Green Med Solution to Acquire Future NRG in All-Stock Exchange; Sellers to Own >99% - tradingview.com

<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxOMm9ZOU1kaUN1NGhscWt2UW0xUm12YnR3WXdwQWlYbVlOVXBtX1JrNktyT1hIdHE5V2FaRXo5ZHU0UzA5b25kSjZaYU0tWWZpLUVvanRUdlhkQlBmeWh3aUxPYU5kVC1TTkhfMWlfUW5GclU4bmRmWVlmVmZwM0h4aHE2ekpwR0RSbWRqZm…

Google News hu, 04 Jun 2026

Stocks to watch on Thursday after-hours: LULU, RBRK, BGMS, DOCU (LULU:NASDAQ) - Seeking Alpha

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNSmVWNmVDeGlrM0U1SVVKNTdyVkl2N3dweHBTbFRyS0ZBTmdtc3ZRYm8ta1RFXzg2M253TEZSd1JGZkIwQThpc1VOWk52QXQ5UnlvNHBqVW8yQ2JKQ0o2cEtqZ3ZUNUFzVmM0ZkcyNElKcnpSWnlIYXVManBHeGg0TTRILTloMG1ZYlJlUU…

Google News hu, 28 May 2026

BGMS - Finviz

<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTFBqMHJtN2hUTXVqRWZmdjB1WGwxR2FyRTJUZWJRNDZIb0laaE5VNThldFRqdXJTbV9YbDZia3NBZFUxMGFpWFE?oc=5" target="_blank">BGMS</a>&nbsp;&nbsp;<font color="#6f6f6f">Finviz</font>…

Google News Fri, 05 Jun 2026

Bio Green Med Solution Surges 172% After Announcing Deal to Acquire Malaysia Waste Tech Company - Benzinga

<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxPYkcyaXhXXzhpb0otUHJUWm5aX1hkRWxjMDZGOUpIcFVwYVFuR1p3UXU3aUF0NFlJSmpzRlc3NmFjbWlXdkdLbXVQRTBFZFhqaGFXSzNNdXgwcTF2bktnQTdmeXdlOFhRS0N4T080X1Q3OGtfZTh0SG54SnI4NE5IRFN5U3hDdW5ncHl1an…

BGMS — Frequently Asked Questions

What is the current share price of Bio Green Med Solution, Inc. (BGMS)?

As of 2026-09-19 21:16 PDT, Bio Green Med Solution, Inc. (BGMS) trades at $0.87 on NasdaqCM. Its 52-week range is $0.60 to $8.90.

What is the market capitalisation of BGMS?

Bio Green Med Solution, Inc. (BGMS) has a market capitalisation of $5.76M on NasdaqCM.

What is the P/E ratio of BGMS?

BGMS trades at a trailing price-to-earnings (P/E) ratio of -0.18. The industry average P/E is 26.00. Its price-to-book (P/B) ratio is 0.79.

What is the return on equity (ROE) of BGMS?

BGMS has a return on equity (ROE) of 34.40%. Its return on capital employed (ROCE) is -122.97%.

Is BGMS a good stock to buy?

This page provides a data-driven analysis of Bio Green Med Solution, Inc. (BGMS), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Industrials Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space